Literature DB >> 8949726

Unilateral ocular cicatricial pemphigoid with circulating IgA and IgG autoantibodies reactive with the 180 kD bullous pemphigoid antigen.

T Matsuzaki, Y Mashima, T Idei, T Hashimoto, Y Mashima.   

Abstract

Mesh：

Substances：

Year:  1996        PMID： 8949726      PMCID： PMC505598          DOI： 10.1136/bjo.80.8.769

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN： 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  6 in total

1.  Production of human monoclonal anti-basement membrane zone (BMZ) antibodies from a patient with bullous pemphigoid (BP) by Epstein-Barr virus transformation. Analyses of the heterogeneity of anti-BMZ antibodies in BP sera using them.

Authors:  T Sugi; T Hashimoto; T Hibi; T Nishikawa
Journal:  J Clin Invest       Date:  1989-10       Impact factor: 14.808

2.  The major cicatricial pemphigoid antigen is a 180-kD protein that shows immunologic cross-reactivities with the bullous pemphigoid antigen.

Authors:  P Bernard; C Prost; N Durepaire; N Basset-Seguin; L Didierjean; J H Saurat
Journal:  J Invest Dermatol       Date:  1992-08       Impact factor: 8.551

3.  Identification of a basement membrane zone antigen reactive with circulating IgA antibody in ocular cicatricial pemphigoid.

Authors:  E P Smith; T B Taylor; L J Meyer; J J Zone
Journal:  J Invest Dermatol       Date:  1993-10       Impact factor: 8.551

4.  Differentiating anti-lamina lucida and anti-sublamina densa anti-BMZ antibodies by indirect immunofluorescence on 1.0 M sodium chloride-separated skin.

Authors:  W R Gammon; R A Briggaman; A O Inman; L L Queen; C E Wheeler
Journal:  J Invest Dermatol       Date:  1984-02       Impact factor: 8.551

5.  Identification of cicatricial pemphigoid antigens.

Authors:  Y Niimi; X J Zhu; J C Bystryn
Journal:  Arch Dermatol       Date:  1992-01

Review 6.  Cicatricial pemphigoid.

Authors:  A R Ahmed; B S Kurgis; R S Rogers
Journal:  J Am Acad Dermatol       Date:  1991-06       Impact factor: 11.527
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.